These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18220638)

  • 21. The Hypertension in Diabetes Study (HDS): a catalyst for change.
    Williams B
    Diabet Med; 2008 Aug; 25 Suppl 2():13-9. PubMed ID: 18717973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of oral hypoglycemic agents in therapy and prevention of macrovascular complications.
    Krall LP
    Horm Metab Res Suppl; 1985; 15():98-101. PubMed ID: 3908284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diabetic hypertensive (or hypertensive diabetic)--a compelling need to optimize blood pressure.
    Carruthers SG
    Adv Exp Med Biol; 2001; 498():119-25. PubMed ID: 11900359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of type 2 diabetes.
    McFarlane SI; Shin JJ; Rundek T; Bigger JT
    Curr Diab Rep; 2003 Jun; 3(3):235-41. PubMed ID: 12762972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic control and complications in type 2 diabetes mellitus.
    Stolar M
    Am J Med; 2010 Mar; 123(3 Suppl):S3-11. PubMed ID: 20206730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
    Goodarzi MO; Psaty BM
    JAMA; 2008 Nov; 300(17):2051-3. PubMed ID: 18984894
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood pressure control in type 2 diabetes mellitus.
    Krantz MJ
    Ann Intern Med; 2004 Mar; 140(6):487; author reply 487-8. PubMed ID: 15023718
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic intervention in the GLP-1 pathway in Type 2 diabetes.
    Levy JC
    Diabet Med; 2006 Mar; 23 Suppl 1():14-9. PubMed ID: 16483260
    [No Abstract]   [Full Text] [Related]  

  • 29. Captopril-induced acute pancreatitis.
    Jeandidier N; Klewansky M; Pinget M
    Diabetes Care; 1995 Mar; 18(3):410-1. PubMed ID: 7555489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive treatment and mortality in diabetic patients. What is the evidence?
    Sawicki PT; Heise T; Berger M
    Diabetologia; 1997 Jul; 40 Suppl 2():S134-7. PubMed ID: 9248721
    [No Abstract]   [Full Text] [Related]  

  • 31. Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin-angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20).
    Erdmann E; Spanheimer R; Charbonnel B;
    J Diabetes; 2010 Sep; 2(3):212-20. PubMed ID: 20923486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus.
    Snow V; Weiss KB; Mottur-Pilson C;
    Ann Intern Med; 2003 Apr; 138(7):587-92. PubMed ID: 12667031
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmaco-economics of type 2 diabetes].
    Scheen AJ; Lefèbvre PJ
    Rev Med Liege; 1998 May; 53(5):285-9. PubMed ID: 9689884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis.
    Gargiulo P; Savarese G; D'Amore C; De Martino F; Lund LH; Marsico F; Dellegrottaglie S; Marciano C; Trimarco B; Perrone-Filardi P
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1081-1088. PubMed ID: 29113708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACE inhibitors and cardiovascular protection in diabetes.
    Donnelly R
    Diabetes Obes Metab; 2004 Nov; 6(6):399-401. PubMed ID: 15479215
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of intensive glucose control on microvascular events in people with type 2 diabetes.
    Drug Ther Bull; 2017 Jun; 55(6):62. PubMed ID: 28566321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing macrovascular complications in type 2 diabetes mellitus: glucose control and beyond.
    Stancoven A; McGuire DK
    Am J Cardiol; 2007 Jun; 99(11A):5H-11H. PubMed ID: 17665747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summaries for patients. Blood pressure control in people with type 2 diabetes mellitus: recommendations from the American College of Physicians.
    American College of Physicians
    Ann Intern Med; 2003 Apr; 138(7):I70. PubMed ID: 12667047
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
    Lebovitz HE
    Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.